Results 131 to 140 of about 65,545 (257)

Venous Thromboembolism in Hematologic Malignancies: Incidence, Risk Factors, and the Role of Direct Oral Anticoagulants

open access: yesEuropean Journal of Haematology, Volume 117, Issue 6, Page 1421-1441, December 2026.
ABSTRACT Thrombotic events, particularly venous thromboembolism (VTE), are a significant source of morbidity and mortality among patients with hematologic malignancies. These patients face unique challenges due to treatment‐related complications such as thrombocytopenia, coagulopathy, and heightened bleeding risk.
Mario Biglietto   +12 more
wiley   +1 more source

Thromboembolism and Bleeding Risks in Atrial Fibrillation: Outcomes of Oral Anticoagulation After Catheter Ablation. [PDF]

open access: yesJ Am Heart Assoc
Ren L   +26 more
europepmc   +1 more source

Assessment of Thrombin Generation in Pediatric Patients on Extracorporeal Life Support: Impact of Bivalirudin and Other Anticoagulants

open access: yesInternational Journal of Laboratory Hematology, Volume 48, Issue 6, Page 1472-1476, December 2026.
ABSTRACT Introduction Bivalirudin is an alternative anticoagulant to heparin and is widely used in pediatric extracorporeal life support (ECLS). Its activity is monitored using activated partial thromboplastin time (aPTT) and/or more specific tests such as plasma‐diluted thrombin time (dTT).
Vadim Kostousov   +3 more
wiley   +1 more source

Pharmacist management of oral anticoagulation for atrial fibrillation in the community: The APOTHECARY AF study. [PDF]

open access: yesHeart Rhythm O2
Blyler CA   +6 more
europepmc   +1 more source

Drug Discovery for Snakebite Envenoming: Wanderings Amid Historical Antidotes and Emerging Therapeutic Opportunities

open access: yesChemMedChem, Volume 21, Issue 21, 12 November 2026.
In this review, we provide an overview of selected historical antidotes against snakebite envenomation used in early modern Europe. Then, the evidence‐based antivenom activity of some natural compounds is discussed as resulting from more than two decades of research studies.
Elisa Bianconi   +3 more
wiley   +1 more source

Assessing the Sensitivity and the Clinical Impact of the 2023 American College of Rheumatology/EULAR Classification Criteria in Obstetric Antiphospholid Syndrome: Findings From a Multicenter Italian Cohort With a Long‐Term Follow‐Up

open access: yesArthritis Care &Research, Volume 78, Issue 11, Page 1691-1700, November 2026.
Objective The aim of this study was to evaluate the sensitivity of the 2023 American College of Rheumatology (ACR)/EULAR classification criteria for antiphospholipid syndrome (APS) in a real‐world cohort of women diagnosed with primary obstetric APS (oAPS) and to assess their ability to identify patients at risk of future pregnancy complications ...
Francesca Ruffilli   +10 more
wiley   +1 more source

Mobile health interventions to improve adherence to oral anticoagulant treatment: A systematic review and critical analysis

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 11, Page 3733-3758, November 2026.
Aims Non‐adherence to oral anticoagulants (OACs) is associated with significant morbidity and mortality. Mobile health (mHealth) interventions have been used to improve medication adherence across the three phases of initiation, implementation and persistence.
Non Davies   +2 more
wiley   +1 more source

Elevated Systemic Inflammation Response Index on Admission Indicates Stress Ulcer Risk in Acute Ischemic Stroke

open access: yesBrain and Behavior, Volume 16, Issue 11, November 2026.
ABSTRACT Background Stress ulcers following acute ischemic stroke worsen prognosis and increase healthcare burden. Inflammatory mechanisms are involved, yet the association between the systemic inflammation response index (SIRI) and ulcer risk remains unclear. This study investigates the correlation between SIRI levels and post‐stroke stress ulcer risk.
Yang Yang   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy